Projects per year
Personal profile
Biography
Dr Michael Fahey
School of Clinical Sciences at Monash Health
Monash Medical Centre
Telephone: +61 3 9594 3499
Email: [email protected]
Areas of expertise
- Commentary: Paediatric neurology; Neurogenetics.
- Supervision: Neurology; Neurogenetics; Cerebral palsy.
Neurogenetics
In Australia, a child is born with Cerebral Palsy every 18 hours. As a physician and the Head of Paediatric Neurology at Monash Medical Centre, Dr Michael Fahey is too familiar with the human face of the condition. However, as a researcher specialising in neurogenetics, Michael also knows there is work underway that could one day lead to a cure.
Neurogenetics is concerned with the link between our genes and the diseases and disorders of the nervous system. Michael's research focuses on using neurogenetics to understand the causes of movement disorders and diseases of the muscle and nerve. These include Cerebral Palsy, a disease that affects thousands of Australians.
While scientific researchers of Michael's standing - he has undertaken research and training with Monash University, Melbourne University, the Royal Australasian College of Physicians, the Alfred Hospital, Sydney Children's Hospital and the Murdoch Children's Research Institute - are cautious about raising expectations about the possibility of finding a cure for disorders such as Cerebral Palsy, he is excited by the insights genetic research is generating.
"The next stage of research into these conditions is going to be to try and evolve treatments for them," Michael says.
"At the moment these are conditions which we are becoming increasingly good at diagnosing and a genetic diagnosis will allow us to understand the mechanisms behind the disease. Our hope is that for many of the conditions that we're looking at treatments that will be developed within my working lifespan.
"this is about moving beyond managing the disease to actively look for cures. That's our motivation, and I hope this is real. This kind of research works on long timescales, I think that's fair to say, but it's always hoped that treatments will evolve quickly from the discover of the causes behind the condition."
Michael believes that Monash and its network of partners are in a great position to be world leaders in the field. He is currently collaborating on research into treatments for Cerebral Palsy with researchers at the Ritchie Centre, part of the Monash Institute of Medical Research. The work has evolved out of Ritchie Centre strengths in women's health and foetal and newborn medicine. It focuses on melatonin, a hormone produced in the brain, and Michael is confident the research will soon move to human trials.
In addition to working with the Ritchie Centre, Michael also collaborates on gene discovery research with Genetic Health Services Victoria and experts at the Alfred Hospital. He is also involved in the treatment of rare neuro-metabolic diseases with partners at the Royal Melbourne Hospital.
Outside of the lab, Michael maintains a heavy workload as a physician. He is Head of the Paediatric Neurology Unit at Monash Medical Centre, and works in neurogenetics clinics at the Royal Melbourne and St Vincents Hospitals. He is also collaborating with Professor Elsdon Storey, Head of the Neurology and Stroke Unit at the Alfred. He still finds the time to act as neurologist at the Paediatric Rehabilitation Clinic and has co-founded a mitochondrial clinic.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
A phase III double-blinded, randomised, placebo-controlled study investigating the efficacy and safety of NTI164 in children and young adults with Autism Spectrum Disorder.
Fahey, M. (Primary Chief Investigator (PCI))
17/09/26 → 16/09/31
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy.
Fahey, M. (Primary Chief Investigator (PCI))
30/08/23 → 29/08/28
Project: Research
-
A Phase 2, multicenter, open-label, long-term safety study of LP352 in subjects with developmental and epileptic encephalopathy who completed Study LP352-201 and are candidates for continuous treatment for up to 52 weeks
Fahey, M. (Primary Chief Investigator (PCI))
25/07/23 → 24/07/28
Project: Research
-
Investigating the effects of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) on gene regulation and immune dysfunction in paediatric acute-onset neuropsychiatric syndrome: An open-label study
Fahey, M. (Primary Chief Investigator (PCI))
25/07/23 → 24/07/28
Project: Research
-
MitoHOPE: Introducing Mitochondrial Donation in Australia: The MitoHOPE (Healthy Outcomes Pilot and Evaluation) Program
Carroll, J. (Primary Chief Investigator (PCI)), Herbert, M. (Chief Investigator (CI)), Christodoulou, J. (Chief Investigator (CI)), Thorburn, D. R. (Chief Investigator (CI)), Mills, C. (Chief Investigator (CI)), Zander-Fox, D. L. (Chief Investigator (CI)), Robker, R. (Chief Investigator (CI)), Rombauts, L. (Chief Investigator (CI)), Sallevelt, S. (Chief Investigator (CI)), Ludlow, K. (Chief Investigator (CI)), Coman, D. J. (Chief Investigator (CI)), Ellaway, C. (Chief Investigator (CI)), Mackey, D. A. (Chief Investigator (CI)), Delatycki, M. (Chief Investigator (CI)), Yau, W. Y. (Chief Investigator (CI)), Tchan, M. C. (Chief Investigator (CI)), Long, J. C. (Chief Investigator (CI)), Hardy, T. (Chief Investigator (CI)), Adhikari, D. (Chief Investigator (CI)), Choudhary, M. (Chief Investigator (CI)), Hyslop, L. A. (Chief Investigator (CI)), Mann, J. (Chief Investigator (CI)), Ryan, M. (Chief Investigator (CI)), Hodges, R. (Chief Investigator (CI)), Hui, L. (Chief Investigator (CI)), Kamien, B. A. (Chief Investigator (CI)), Mallett, A. J. (Chief Investigator (CI)), Wallis, M. (Chief Investigator (CI)), Wall, M. (Chief Investigator (CI)), Zoungas, S. (Chief Investigator (CI)), Goranitis, I. (Chief Investigator (CI)), Gyngell, C. (Chief Investigator (CI)), Hammarberg, K. (Chief Investigator (CI)), Sparrow, R. (Chief Investigator (CI)), Warren, N. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Stutterd, C. A. (Associate Investigator (AI)), Schweitzer, D. R. (Associate Investigator (AI)), McGillivray, G. (Associate Investigator (AI)), Savulescu, J. (Associate Investigator (AI)), Panetta, J. (Associate Investigator (AI)), Kava, M. P. (Associate Investigator (AI)), Freckmann, M.-L. (Associate Investigator (AI)), Lynch, M. (Associate Investigator (AI)), Lamont, P. J. (Associate Investigator (AI)), Scott, R. (Associate Investigator (AI)), Ware, T. (Associate Investigator (AI)), Mowat, D. (Associate Investigator (AI)), Jones, K. J. (Associate Investigator (AI)), Green, S. (Associate Investigator (AI)), Wolfe, R. (Associate Investigator (AI)), Hackett, A. (Associate Investigator (AI)), Bratkovic, D. (Associate Investigator (AI)), Horton, A. (Associate Investigator (AI)) & Blok, R. (Project Manager)
Monash University – Internal Faculty Contribution, Australian Genomics, James Cook University, Lyons Eye Institute Limited, Macquarie University, Murdoch Children's Research Institute, Australian Mitochondrial Disease Foundation Limited (trading as Mito Foundation), Monash IVF Group Limited, Perron Institute for Neurological and Translational Science Limited, Queensland Children's Hosptial , Tasmanian Clinical Genetics Service, Adelaide University, Victorian Assisted Reproductive Treatment Authority (VARTA) (Victoria), Women's and Children's Health Care Network Incorporated, Western Sydney Local Health District (WSLHD)
1/06/23 → 31/05/29
Project: Research
-
A description and a diagnostic framework: Synergy for practical cerebral palsy diagnosis and care
Aravamuthan, B., Fehlings, D., Novak, I., Fahey, M., Fowler, E., Kruer, M. & Chambers, H., Apr 2026, In: Developmental Medicine and Child Neurology. 68, 4, p. 581-582 2 p.Research output: Contribution to journal › Letter › Other › peer-review
-
From waitlists to clinical action: pathway development and research priorities in childhood developmental regression
Furley, K., Boterberg, S., Fahey, M., Goin-Kochel, R. P., Willis, S., Absoud, M. & Williams, K., Oct 2026, In: The Lancet Child & Adolescent Health. 10, 10, p. 691-693 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
-
Incidence of Childhood Stroke and Association With Recent Infection: A Population-Based Study Using Linked Data
Dalli, L. L. (Leading Author), Olaiya, M. T., Morgan, H. J., Kilkenny, M. F., Fahey, M. C., Mackay, M. T., Cadilhac, D. A., Kuo, T. Y., Gall, S. L., Clothier, H. J., Boyle, J. A., Mallard, J., Hennessy, D. & Buttery, J. (Leading Author), 14 Apr 2026, In: Neurology. 106, 7, 12 p., e214704.Research output: Contribution to journal › Article › Research › peer-review
1 Link opens in a new tab Citation (Scopus) -
Preliminary safety, tolerability and feasibility of remotely supervised transcranial direct current stimulation in children with cerebral palsy: an exploratory, open label clinical trial
Griffin, A., Fahey, M. C., Blatch-Williams, R., Finch-Edmondson, M., Kanhangad, M., Novak, I., Mc Namara, M., Paton, M. C., Webb, A. & Gillick, B. T., Sept 2026, In: Brain Stimulation. 19, 5, 4 p., 103195.Research output: Contribution to journal › Letter › Research › peer-review
Open Access -
Short corpus callosum on fetal magnetic resonance imaging: clinical outcomes and genetic associations
Klapczynski, C. E., Rolnik, D. L., Fahey, M. & Goergen, S. K., Sept 2026, In: Ultrasound in Obstetrics and Gynecology. 68, S1, p. 190 1 p., EP06.60.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access